Four cases of tumorous endobronchial tuberculosis (EBTB) were prospectively evaluated to assess the effect of antitubercular treatment (ATT) on tumorous EBTB. All 4 patients received standard ATT (isoniazid, rifampicin, ethambutol, and pyrizinamide for 2 months followed by isoniazid and rifampicin). At the completion of ATT, bronchoscopy was repeated in all cases and no residual structural abnormality of the bronchus was identified. Short-course ATT without corticosteroid is effective in preventing residual endobronchial complication of tumorous EBTB.
Supplemental Digital Content is available in the text.
Department of Tuberculosis and Respiratory Disease, Mahatma Gandhi Institute of Medical Sciences, Maharashtra, India
Reprints: Sajal De, MD, FCCP, Qr No-8, Type III, Vivekananda Colony, MGIMS Campus, Sevagram, Maharashtra 442102, India (e-mail: firstname.lastname@example.org).
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the Journal's Web site (www.bronchology.com).
Received December 19, 2010
Accepted February 14, 2011